ENTEROMEDICS INC. (NASDAQ:ETRM) Files An 8-K Other Events
Item8.01
| Other Events. |
Clinical Practice Weight Loss Data
On December15, 2016, EnteroMedics Inc. (the Company) issued a
press release to disclose certain clinical practice weight loss
data in patients using the Companys vBloc Therapy in combination
with vBloc Achieve. A copy of this press release is filed as
Exhibit 99.1 to this Current Report on Form 8-K and is
incorporated herein by reference.
Outstanding Share Update
On December20, 2016, the Company announced that, as of
December16, 2016, there were 167,241,668 shares of the Companys
common stock issued and outstanding, an increase of 27,371,201
shares since December12, 2016, the last date for which the
Company had publically announced its issued and outstanding share
count. The increase in the Companys share count is a result of
the conversion or acceleration of outstanding principal and
interest amounts of the Companys outstanding 7.0% senior
amortizing convertible notes (the Notes) by the holders of the
Notes.
| Item9.01 | Financial Statements and Exhibits. |
(d) Exhibits
|
Exhibit No. |
Description |
|
| 99.1 |
Press Release issued by EnteroMedics Inc. dated December15, 2016. |
About ENTEROMEDICS INC. (NASDAQ:ETRM)
